↓ Skip to main content

Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, October 2020
Altmetric Badge

Mentioned by

twitter
1 tweeter

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
Published in
Breast Cancer Research and Treatment, October 2020
DOI 10.1007/s10549-020-05978-8
Pubmed ID
Authors

Gwen M. H. E. Dackus, Katarzyna Jóźwiak, Elsken van der Wall, Paul J. van Diest, Michael Hauptmann, Sabine Siesling, Gabe S. Sonke, Sabine C. Linn

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 25%
Researcher 1 25%
Other 1 25%
Unknown 1 25%
Readers by discipline Count As %
Unspecified 1 25%
Psychology 1 25%
Medicine and Dentistry 1 25%
Unknown 1 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2020.
All research outputs
#14,731,513
of 16,699,900 outputs
Outputs from Breast Cancer Research and Treatment
#3,380
of 3,835 outputs
Outputs of similar age
#320,339
of 382,901 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#51
of 62 outputs
Altmetric has tracked 16,699,900 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,835 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 382,901 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.